Consistent with previous reports that gene mutations or increased protein levels of PQBP3/NOL7 are associated with various cancers (Pinho et al, 2019; Hasina et al, 2006; Doçi et al, 2012; Li et al, 2021), our findings indirectly suggested that PQBP3/NOL7 increases cellular resilience and resistance to cell death in some contexts. Here, NOL7 is linked to cancer.